Keyword Suggestion
Domain Informations
Beleodaq.com lookup results from whois.fastdomain.com server:
- Domain created: 2013-10-25T11:40:36Z
- Domain updated: 2025-10-10T07:10:49Z
- Domain expires: 2026-10-25T11:40:36Z 0 Years, 126 Days left
- Website age: 12 Years, 238 Days
- Registrar Domain ID: 1832464176_DOMAIN_COM-VRSN
- Registrar Url: https://www.bluehost.com
- Registrar WHOIS Server: whois.fastdomain.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +1.6028175172
- Name server:
- NS1.HOSTMONSTER.COM
- NS2.HOSTMONSTER.COM
Network
- inetnum : 74.220.192.0 - 74.220.223.255
- name : BLUEHOST-NETWORK-2
- handle : NET-74-220-192-0-1
- status : Direct Allocation
- created : 2006-08-08
- changed : 2025-07-24
- desc : OCITOKEN::74.220.200.0/21:75427c88ae6d91201f9c854fec18321d15e066826826c00eab7f160eedca4a8d,OCITOKEN::74.220.212.0/23:0c3feac6ee3eeb8a0d258da3b67e04a67475d724953af80246e6494ea91e6b55,OCITOKEN::74.220.214.0/23:5f7c941f28c9a67193adef7713b34cb3a9a4a9428db8b80961b2c48187b1b9b4,OCITOKEN::74.220.220.0/22:d2cd333095f8396cc864512e1e29ab2ed0492005af12b11b750786606326f107,OCITOKEN::74.220.198.0/23:8c808e60261e6f9685e339b0bf9eaea9c697548cecec86cb37ad611ad0d9987e,OCITOKEN::74.220.192.0/22:adcbe387baa549a42f728a1458a22d9b278fd306405715e6f579dc62934d3c59,OCITOKEN::74.220.208.0/22:f71d74610f9213f0751b23889671f719ec27aaeb6e995ec0b50b804dc0dc552e,OCITOKEN::74.220.216.0/22:1f9d731067c9ceafd6d9c259fe4eeedda447c3670878332657d388eb9432caa6
Owner
- organization : Unified Layer
- handle : BLUEH-2
- address : Array,Provo,UT,84606,US
Abuse
- handle : EIGAB1-ARIN
- name : EIG-Abuse Mitigation
- phone : +1-877-659-6181
- email : [email protected],[email protected]
Technical support
- handle : NETWO2081-ARIN
- name : Network Operations
- phone : +1-801-765-9400
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 74.220.203.200
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Timezone: America/Denver
Site Inspections
Port Scanner (IP: 74.220.203.200)
Spam Check (IP: 74.220.203.200)
Recent Searched Sites
› Falkentyre.com (0 seconds ago) / DE
› Macros.io (1 mins ago) / US
› Pornowhats.com (3 seconds ago) / NL
› Daystarins.com (5 seconds ago) / US
› Instituterank.com (1 seconds ago) / US
› Vcook.jp (25 seconds ago) / US
› Beleodaq.com (1 seconds ago) / US
› Uca.co.jp (17 seconds ago) / JP
› Unil.co.kr (20 seconds ago) / KR
› Tvsetdvd.com (10 seconds ago) / US
› Fbisupport.com (34 seconds ago) / US
› Nagoya-schoolnursing.jp (31 seconds ago) / JP
› Num.auto.az (1 seconds ago) / US
› Standupvc.com (3 seconds ago) / US
› Dou.diso.ru (16 seconds ago) / RU
› H-k.live (6 seconds ago) / US
› Reservasonlinebrasil.com.br (9 seconds ago) / US
› Negozona.com.mx (23 seconds ago) / US
› Geniusdevs.com (20 seconds ago) / US
› Debrakenya.com (3 seconds ago) / US
Websites Listing
We found Websites Listing below when search with beleodaq.com on Search Engine
BELEODAQ (belinostat) for injection - for Healthcare …
BELEODAQ is a histone deacetylase inhibitor indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This indication is approved under …
Beleodaq.comBeleodaq Injection - FDA prescribing information, side …
2021-12-01 · The safety of Beleodaq was evaluated in 129 patients with relapsed or refractory PTCL in the single arm clinical trial in which patients were administered Beleodaq at a dosage …
Drugs.comBeleodaq (Belinostat for Injection for Intravenous Use): …
2022-04-28 · The safety of Beleodaq was evaluated in 129 patients with relapsed or refractory PTCL in the single arm clinical trial in which patients were administered Beleodaq at a dosage …
Rxlist.comBeleodaq - Side Effects, Uses, Dosage, Overdose, Pregnancy
2014-07-03 · Beleodaq is a prescription medication used for the treatment of patients with peripheral T-cell lymphoma (PTCL), a rare and fast-growing type of non-Hodgkin lymphoma …
Rxwiki.comBeleodaq Coupon & Prices - Cost $49 per month
Beleodaq is available in injection form, in the following doses: 500 mg, lyophilized powder in a single-use vial for reconstitution. The recommended dosage of Beleodaq is 1,000 mg/m2 …
Nicerx.comBeleodaq for Peripheral T-Cell Lymphoma – Detail | CADTH
2018-10-24 · Servier Canada Inc. has notified pCODR that the Category 2 submission requirements for the pre NOC submission of Belinostat (Beleodaq) for Peripheral T-Cell …
Cadth.caHome - Acrotech Biopharma, LLC
The most common adverse reactions observed in the trial in patients with relapsed or refractory PTCL treated with BELEODAQ were nausea (42%), fatigue (37%), pyrexia (35%), anemia …
Acrotechbiopharma.comBeleodaq: Bula original, extraída manualmente da Anvisa | CR
Beleodaq ® será administrado em você através de infusão intravenosa (IV) nas veias, usualmente durante 30 minutos; ; Beleodaq ® será administrado uma vez ao dia nos Dias 1 …
Consultaremedios.com.brBeleodaq® (belinostat)
Beleodaq 500 mg powder for injection: 25 vials per 21 days B. Max Units (per dose and over time) [ HCPCS U nit ]: x All indications: 1,250 billable units every 21 days III. Initial Approval …
Preferredone.comHIGHLIGHTS OF PRESCRIBING INFORMATION
Beleodaq can cause fatal hepatotoxicity and liver function test abnormalities [see Adverse Reactions (6.1)]. Monitor liver function tests before treatment and before the start of each …
Accessdata.fda.govOur Products - Acrotech Biopharma, LLC
The most common adverse reactions observed in the trial in patients with relapsed or refractory PTCL treated with BELEODAQ were nausea (42%), fatigue (37%), pyrexia (35%), anemia …
Acrotechbiopharma.comBeleodaq - API Insights | Market Research Reports® Inc.
2019-01-17 · Beleodaq - API Insight, 2019 report provides product and API manufacturers’ details across the globe along with the location. The report gives the clear idea on the country …
Marketresearchreports.com贝利司他 Belinostat 靶向药 - 癌症123
贝利司他于2014年7月3日获fda批准上市，用于治疗复发性或难治性的外周t细胞淋巴瘤。 2015年销售额为0.1亿美元。 贝利司他是组蛋白去乙酰化酶（hdac）抑制剂，选择性引起乙酰化组蛋 …
Cancer123.comVI. VII. - Moda Health
2022-05-02 · − Beleodaq 500 mg powder for injection: 25 vials per 21 days B. Max Units (per dose and over time) [HCPCS Unit]: • All indications: 1,250 billable units every 21 days III. …
Modahealth.comDailyMed - BELEODAQ- belinostat injection, powder, lyophilized, …
2014-05-14 · The pKa values are 7.87 and 8.71 by potentiometry and 7.86 and 8.59 by UV. Beleodaq (belinostat) for injection is supplied as a sterile lyophilized yellow powder containing …
Dailymed.nlm.nih.govBeleodaq Intravenous: Uses, Side Effects, Interactions ... - WebMD
Find patient medical information for Beleodaq intravenous on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Webmd.comBELEODAQ Prescribing Information - MedicationDiscountCard.com
Contraception Females Beleodaq can cause embryo-fetal harm when administered to a pregnant woman [ see Use in Specific Populations ( 8.1 )]. Advise females of reproductive potential to …
Rxgo.comBeleodaq® (belinostat) - Magellan Provider
2020-03-03 · BELEODAQ® (belinostat) Prior Auth Criteria Proprietary Information. Restricted Access – Do not disseminate or copy without approval. ©2020, Magellan Rx Management VI. …
Specialtydrug.magellanprovider.comBeleodaq (Acrotech Biopharma LLC): FDA Package Insert, Page 2
2022-04-18 · The safety of Beleodaq was evaluated in 129 patients with relapsed or refractory PTCL in the single arm clinical trial in which patients were administered Beleodaq at a dosage …
Medlibrary.orgBeleodaq - API Insight, 2022
It includes Beleodaq overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities. It further provides Beleodaq’s patents information (US …
Reportlinker.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| supremelendingdallas.com | wildwestdomains.com | -2 Years, -135 Days |
| edigreen.com | registrar.amazon.com | -3 Years, -111 Days |
| sofinefoods.com | openprovider.com | -4 Years, -30 Days |
| ideaministries.net | namesecure.com | -3 Years, -339 Days |
| milanmantra.com | godaddy.com | -1 Years, -285 Days |
| hawachextractionthimble.com | net.cn | -3 Years, -317 Days |
| lyconet.com | eurodns.com | -4 Years, -23 Days |
| prestige-modelmanagement.com | hetzner.com | -4 Years, -69 Days |
| 0141kaki.com | gmo.jp | -3 Years, -185 Days |
| iraqcenter.net | publicdomainregistry.com | -3 Years, -275 Days |